Page 6 - Project
P. 6
The Allermetrix Peanut Panel helps to identify patients at risk for “true” peanut allergy
and identifies potentially important clinical cross-reactants. The patient history and
physician’s clinical findings must always guide the care for the patient. If strict peanut
avoidance is maintained in the household, children may not be exposed and therefore
may not have had a priming exposure necessary to elicit antibody formation. It is
important to consider the likelihood of exposure when evaluating negative findings.
Laboratory results indicating low risk patients do not preclude the possibility of
these patients experiencing peanut reactions.
5 | P a g e
